Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Advanced Solid Tumours 5Squamous Cell Carcinoma of Head and Neck 3Solid Tumors 2Small Cell Lung Carcinoma 2Ovarian Neoplasms 2Leukemia, Myeloid, Acute 2Glioblastoma 2Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Muscle Invasive Bladder Cancer 1Meningeal Carcinomatosis 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Laryngeal Neoplasms 1Head and Neck Neoplasms 1Gliosarcoma 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Colorectal Neoplasms 1Carcinoma, Endometrioid 1Brain Neoplasms 1Blast Crisis 1Astrocytoma 1Advanced Solid Tumors 1Adenocarcinoma Of Esophagus 1

Interventions

Cytarabine 11Cyclophosphamide 10Filgrastim 9Etoposide 8fludarabine phosphate 6Vorinostat 6Tacrolimus 6Peripheral Blood Stem Cell Transplantation 6Imatinib Mesylate 6Dasatinib 6Carboplatin 5tipifarnib 4sargramostim 4Topotecan 4Sirolimus 4Bortezomib 4tanespimycin 3fludarabine 3alvocidib 3Whole-Body Irradiation 3Sorafenib 3Flow Cytometry 3Doxorubicin 3Decitabine 3Busulfan 3Antilymphocyte Serum 33-aminopyridine-2-carboxaldehyde thiosemicarbazone 3laromustine 2entinostat 2bryostatin 1 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Blast Crisis × adavosertib × Clear all
NCT02381548 2026-01-30

Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 1 Terminated
20 enrolled
MyeloidOther hematologic neoplasm

Blast Crisis, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡